Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: combjelly who wrote (682518)	11/2/2012 4:55:04 PM
From: PROLIFE	Read Replies (2) \| Respond to of 1572417

stick to the subject, can you not do that? just because embryos WERE used (big money from the guvmit) does not prove success, dumb ass. If that were the case, I guess Solyndra was a screaming success, huh? Embryonic Stem Cell Research Racks Up Another Failure, Immune System Issues lifenews.com President Barack Obama's recent decision to allow the funding of embryonic stem cell research with millions of taxpayer dollars is deadly for human embryos and completely unnecessary. Embryonic stem cell research has a 100 percent failure rate. oregonlive.com Scientists were shocked by U.S. biotech company Geron Corp's decision on Monday to quit embryonic stem cell research -- a move it blamed on a lack of money and the complexities of getting regulatory approval. reuters.com California’s Institute for Regenerative Medicine came into being five years ago, fueled by a conviction that the Bush administration’s restriction on embryo-destructive research in the National Institutes of Health was stifling the progress of science. But after years of fruitless work, the Institute has now quietly diverted funds from embryonic stem cell research (ESCr) to adult stem cell research - which has already produced dozens of treatments and all-out cures for maladies ranging from spinal cord injury, to Alzheimer’s, to type I diabetes lifesitenews.com